Illumina Inc. (ILMN) on Thursday reported first-quarter results, with profit increasing from last year, driven by higher revenue and improved margins.
Revenue for the quarter rose to $1.09 billion from $1.04 billion in the same period last year.
The company reported net income of $134 million or $0.87 per share, compared with $131 million or $0.82 per share a year ago. Adjusted earnings per share increased to $1.15 from $0.97 last year.
Gross margin for the quarter improved to 66.1% from 65.6%, while operating margin improved to 19.2% from 15.8%.
"Illumina delivered a strong start to 2026, reflecting the strength of the Illumina ecosystem and progress against our strategy," said Jacob Thaysen, Chief Executive Officer of Illumina. "Demand for NovaSeq X is increasing as we help our clinical customers expand into new application areas. With our strong first quarter performance, we are raising our full-year revenue and EPS guidance."
Illumina also raised its full-year 2026 outlook and now expects revenue between $4.52 billion and $4.62 billion, a $20 million increase at the midpoint compared to prior guidance. Adjusted earnings in the range of $5.15 to $5.30 per share, compared to prior guidance of $5.05 to $5.20.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.